Oncology and Hematology News and Journal Articles
Women with diabetes are at a greater risk of being diagnosed with advanced-stage breast cancer, according to a retrospective study. Image © 0833379753 / Shutterstock.com
Combination treatment with the PARP inhibitor olaparib plus the PI3K inhibitor BKM120 showed a benefit in subsets of breast cancer and ovarian cancer patients.
Men with metastatic castration-resistant prostate cancer that had mutations in DNA repair genes were more likely to respond to the PARP inhibitor olaparib.
Women who spend less time eating each day and an increased amount of hours fasting overnight had a decreased risk of breast cancer.
In an ongoing study, the immunotherapy MPDL3280A continues to be well-tolerated and to show signs of activity in triple-negative breast cancer patients.
Treatment with nivolumab and ipilimumab in patients with advanced melanoma produced significantly higher rates of response and progression-free survival compared with ipilimumab alone.
Treatment with pembrolizumab resulted in an estimated 6-month PFS rate that was almost double that of treatment with ipilimumab in advanced melanoma patients.
Ahead of the 2015 AACR Annual Meeting we discuss how insulin resistance relates to current cancer therapies.
In this video we discuss two poster presentations on childhood development and behavior after in utero exposure to chemotherapy for maternal cancer in pregnancy.
In this video from MBCC we discuss a poster presentation on genomic and protein alterations in 126 triple-negative metaplastic breast cancers.
In this video from the 2014 ASH Meeting, Dr. Grupp discusses data from a trial using CAR T-cell therapy in children and young adults with relapsed, treatment-resistant ALL.
In this video from the 2014 ASH Annual Meeting, Dr. Röllig discusses the results of the SORAML trial that tested sorafenib in patients with acute myeloid leukemia.
Over half of all US physicians will be sued for malpractice at some point in their career. Every goody two-shoes knows how to avoid that: be kind and compassionate, yada, yada, yada. Here we reverse the scenario and reveal 15 highly effective habits that, in the face of a bad outcome, might inspire patients to give a personal injury lawyer your address.
This oncology drug snapshot takes a look at axitinib (Inlyta) for the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.
This slide show features some of the top highlights from the 2015 Society of Gynecologic Oncology Annual Meeting, including a vaccine trial in ovarian cancer and a possible biomarker in advanced cervical cancer.
This slide show features micrographs of various types of bone sarcoma, including osteosarcoma, chondrosarcoma, chordoma, Ewing sarcoma, and more.